Equities

Aclaris Therapeutics Inc

Aclaris Therapeutics Inc

Actions
  • Price (USD)15.35
  • Today's Change-0.39 / -2.48%
  • Shares traded300.82k
  • 1 Year change-11.53%
  • Beta0.6633
Data delayed at least 15 minutes, as of Oct 03 2022 21:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • ACRS:NSQ price rises above 50-day moving average to 15.85 at 10:30 BST
  • ACRS:NSQ price moved over -1.23% to 14.49
  • ACRS:NSQ price rises above 50-day moving average to 15.83 at 12:20 BST
  • ACRS:NSQ price falls below 200-day moving average to 14.35 at 10:33 BST
  • ACRS:NSQ price rises above 15-day moving average to 14.73 at 12:40 BST

Key statistics

On Monday, Aclaris Therapeutics Inc (ACRS:NSQ) closed at 15.35, -18.13% below its 52-week high of 18.75, set on Oct 08, 2021.
52-week range
Today
9.26Jan 24 202218.75Oct 08 2021
Markit short selling activity
Low
Med
High
Open15.85
High15.92
Low15.15
Bid6.08
Offer18.80
Previous close15.35
Average volume323.59k
Shares outstanding66.67m
Free float59.63m
P/E (TTM)--
Market cap924.07m USD
EPS (TTM)-1.33
USD
Data delayed at least 15 minutes, as of Oct 03 2022 21:00 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.